Viewing Study NCT00000232


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2026-05-29 @ 4:22 PM
Study NCT ID: NCT00000232
Status: COMPLETED
Last Update Posted: 2016-05-06
First Post: 1999-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Alternate Day Buprenorphine Administration, Phase IX - 14
Sponsor: University of Vermont
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Opioid-Related Disorders View
Keywords: